drugset / Trial / NCT02106559

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

NCT02106559

NaSingle-groupOpen-labelTreatment

Summary

This pilot clinical trial studies photodynamic therapy during surgery in treating patients with pleural (the protective lining or membrane that covers the lungs and chest cavity) malignancy. Photodynamic therapy is an anti-cancer treatment that combines a photosensitizer (a substance that makes cells more sensitive to light), such as porfimer sodium, together with oxygen and visible light to kill tumor cells and/or damage the tumor's blood supply. Intraoperative (during surgery) photodynamic therapy may kill any tumor cells that remain after surgery.

Timeline

Start
2014-09-04
Primary completion
2016-01-29
Completion
2016-01-29

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule Intravenous